Can serum resistin predict severity of acute pancreatitis?

References

• Al-Maramhy, H., Abdelrahman, A.I., and Sawalhi, S., 2014. Resistin is not an appropriate biochemical marker to predict severity of acute pancreatitis: a case-controlled study. World journal of gastroenterology, 20 (41), 15351–15357.
   PubMed Web of Science ®Google Scholar
• Banks, P.A., et al., 2013. Classification of acute pancreatitis-2012: revision of the Atlanta classification and definitions by international consensus. Gut, 62 (1), 102–111.
   PubMed Web of Science ®Google Scholar
• Gharibeh, M., et al., 2010. Plasma resistin with obesity and insulin resistance in type 2 diabetic patients. Diabetes & metabolism, 36 (6), 443–449.
   PubMed Web of Science ®Google Scholar
• Heilbronn, L., et al., 2004. Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. The journal of clinical endocrinology & metabolism, 89 (4), 1844–1848.
   PubMed Web of Science ®Google Scholar
• Kibar, Y.I., et al., 2016. Resistin: new serum marker for predicting severity of acute pancreatitis. The journal of international medical research, 44 (2), 328–337.
   PubMed Web of Science ®Google Scholar
• Kisaoglu, A., et al., 2014. Severity markers in patients with acute pancreatitis. Open medicine, 9 (4), 556–564.
   Google Scholar
• Koch, A., et al., 2009. Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients. Critical care, 13 (3), R95.
   PubMed Web of Science ®Google Scholar
• Lamas, O., Marti, A., and Martínez, J., 2002. Obesity and immunocompetence. European journal of clinical nutrition, 56 (S3), S42–S45.
   PubMedGoogle Scholar
• Lee, J., et al., 2003. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. The journal of clinical endocrinology & metabolism, 88 (10), 4848–4856.
   PubMed Web of Science ®Google Scholar
• Lee, Y. and Pratley, R., 2005. The evolving role of inflammation in obesity and the metabolic syndrome. Current diabetes reports, 5 (1), 70–75.
   PubMedGoogle Scholar
• Mabrouk, R., et al., 2013. Serum visfatin, resistin and IL-18 in a group of Egyptian obese diabetic and non diabetic individuals. Egyptian journal of immunology, 20, 1–11.
   PubMedGoogle Scholar
• Maher, M.M., et al., 2004. Acute pancreatitis: the role of imaging and interventional radiology. Cardiovascular and interventional radiology, 27 (3), 208–225.
   PubMed Web of Science ®Google Scholar
• McTernan, C.L., et al., 2002a. Resistin, central obesity, and type 2 diabetes. Lancet, 359 (9300), 46–47.
   PubMed Web of Science ®Google Scholar
• McTernan, P.G., et al., 2002b. Increased resistin gene and protein expression in human abdominal adipose tissue. The journal of clinical endocrinology & metabolism, 87 (5), 2407–2410.
   PubMed Web of Science ®Google Scholar
• Mery, C., et al., 2002. Android fat distribution as predictor of severity in acute pancreatitis. Pancreatology, 2 (6), 543–549.
   PubMed Web of Science ®Google Scholar
• Misra, A., 2015. Ethnic-specific criteria for classification of body mass index: a perspective for Asian Indians and American diabetes association position statement. Diabetes technology & therapeutics, 17 (9), 667–671.
   PubMed Web of Science ®Google Scholar
• Misra, A., et al., 2009. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. The journal of the Association of Physicians of India, 57, 163–170.
   PubMedGoogle Scholar
• Mortelé, K.J., et al., 2009. CT-guided percutaneous catheter drainage of acute necrotizing pancreatitis: clinical experience and observations in patients with sterile and infected necrosis. American journal of roentgenology, 192 (1), 110–116.
   PubMed Web of Science ®Google Scholar
• Papachristou, G., et al., 2006. Obesity increases the severity of acute pancreatitis: performance of APACHE-O score and correlation with the inflammatory response. Pancreatology, 6 (4), 279–285.
   PubMed Web of Science ®Google Scholar
• Papachristou, G.I., et al., 2010. Comparison of BISAP, Ranson’s, APACHE-II, and CTSI scores in predicting organ failure, complications, and mortality in acute pancreatitis. American journal of gastroenterology, 105, 435–441.
   PubMed Web of Science ®Google Scholar
• Park, H.K., et al., 2017. Linking resistin, inflammation, and cardiometabolic diseases. The Korean journal of internal medicine, 32 (2), 239–247.
   PubMed Web of Science ®Google Scholar
• Parreno Caparros, E., et al., 2017. Resistin in morbidly obese patients before and after gastric bypass surgery. Nutrición hospitalaria, 34, 1333–1337.
   PubMed Web of Science ®Google Scholar
• Schaffler, A., et al., 2010. Admission resistin levels predict peripancreatic necrosis and clinical severity in acute pancreatitis. American journal of gastroenterology, 105, 2474–2484.
   PubMed Web of Science ®Google Scholar
• Smeets, X.J., et al., 2019. The association between obesity and outcomes in acute pancreatitis: an individual patient data meta-analysis. European journal of gastroenterology & hepatology, 31 (3), 316–322.
   PubMed Web of Science ®Google Scholar
• Su, K., et al., 2019. Relation of circulating resistin to insulin resistance in type 2 diabetes and obesity: a systematic review and meta-analysis. Frontiers in physiology., 10, 1399.
   PubMed Web of Science ®Google Scholar
• Valsamakis, G., et al., 2004. Modest weight loss and reduction in waist circumference after medical treatment are associated with favourable changes in serum adipocytokines. Metabolism clinical and experimental., 53 (4), 430–434.
   PubMed Web of Science ®Google Scholar
• van Santvoort, H.C., et al., 2011. A conservative and minimally invasive approach to necrotizing pancreatitis improves outcome. Gastroenterology, 141 (4), 1254–1263.
   PubMed Web of Science ®Google Scholar
• Vendrell, J., et al., 2004. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obesity research, 12 (6), 962–971.
   PubMedGoogle Scholar
• Xue, L.-N., et al., 2015. Significance of resistin expression in acute pancreatitis. Experimental and therapeutic medicine, 9 (4), 1438–1442.
   PubMed Web of Science ®Google Scholar
• Yu, P., et al., 2016. Pancreatology efficacy of resistin and leptin in predicting persistent organ failure in patients with acute pancreatitis. Pancreatology, 16 (6), 952–957.
   PubMed Web of Science ®Google Scholar